Implementation of level-2 biosafety for a macromolecular crystallography beamline at SSRF.

Huating Kong, Minjun Li, Qin Xu, Huan Zhou, Feng Yu, Qisheng WangPubMed 2021

TL;DR

This paper details the successful implementation of a Level-2 biosafety (BSL-2) macromolecular crystallography (MX) beamline at the Shanghai Synchrotron Radiation Facility (SSRF). This novel infrastructure addresses the critical need for studying pathogenic viruses in China, enabling researchers to determine high-resolution structures of these agents safely and effectively.

What Problem Does This Paper Address?

Macromolecular crystallography (MX) is a powerful technique for understanding the structure and function of biological molecules, particularly viruses. However, a significant gap existed in China: the absence of MX beamlines equipped with biosafety measures to handle pathogenic samples. This limitation prevented researchers from studying viruses that pose a threat to public health, such as SARS-CoV-2, within China. Furthermore, the inherent risks associated with handling infectious agents, combined with the radioactive environment of a synchrotron facility, necessitated a specialized infrastructure and stringent operational protocols.

Methods

The core of this paper is the description of the design and implementation of a BSL-2 MX beamline, designated BL10U2, at SSRF. Key methodological aspects include:

  • Dedicated Biosafety Infrastructure: The beamline endstation was redesigned to incorporate a multi-room layout with a negative pressure gradient. This design, featuring five distinct rooms (Room 1: experimental hutch, Room 2: sample preparation/checking, Room 3: sample transfer, Room 4: changing/PPE, Room 5: control/data collection), ensures containment and controlled airflow.
  • Radiation and Biosafety Integration: The design specifically addresses the dual hazards of X-ray radiation and biological agents. This involved lead shielding for radiation protection and specialized containment equipment like a Class II Type A2 biological safety cabinet.
  • Operational Protocols: A comprehensive set of operational procedures was developed, encompassing proposal management, sample handling, personnel training, and environmental disinfection. This includes mandatory online and onsite training for users, a detailed risk assessment process for proposals, and strict protocols for sample transportation, preparation, and disposal.
  • In-situ Data Collection: A specific "in-situ" data collection mode was implemented. In this mode, virus crystals are sealed in tiny cells within crystallization plates, minimizing direct handling and reducing biohazard risks.

Datasets

Not discussed in the paper. The paper focuses on the infrastructure and operational procedures for handling biological samples, rather than specific datasets for training or evaluation.

Key Insights and Ideas

  • Bridging the Gap for Virus Research: The establishment of this BSL-2 MX beamline is a crucial step in advancing virology research in China, enabling the study of previously inaccessible pathogenic agents.
  • Integrated Safety Design: The successful integration of both radiation safety and biosafety measures within a single beamline is a significant engineering and operational achievement.
  • User-Centric Safety Management: The emphasis on comprehensive user training, rigorous proposal review, and clear operational procedures highlights a proactive approach to ensuring safety for both researchers and the environment.
  • The Power of In-Situ Crystallography: The recommendation and implementation of in-situ data collection for hazardous samples underscore its importance in minimizing risks while still obtaining valuable structural data.

Key Results

The paper reports the successful implementation and certification of the BL10U2 BSL-2 MX beamline. While quantitative results on the number of structures determined or specific experimental outcomes are not detailed, the key result is the establishment of a functional and safe facility. The beamline is designed to handle inactivated virus crystals from 39 specific species, including those relevant to SARS-CoV-2 research. The operational procedures and safety infrastructure have been certified by the Shanghai Pudong Municipal Health Commission.

Limitations and Future Work

  • Limited to Inactivated Samples: Currently, the beamline is restricted to handling only inactivated virus crystals. This limitation is due to the BSL-2 designation and the current infrastructure.
  • Potential for Expansion: The authors express a desire to explore more biomedical applications by adding further experimental equipment, suggesting a future direction for enhancing the beamline's capabilities.
  • Focus on Specific Pathogens: While the beamline is designed for a range of pathogenic agents, its immediate focus is on viruses, particularly in the context of emerging infectious diseases like SARS-CoV-2. Future work might involve expanding its scope to other types of biohazards.

Summary updated

Abstract

Macromolecular crystallography is commonly used to determine the structure of biological macromolecules. Currently the beamlines at synchrotron radiation facilities play an important role in macromolecular crystallography, and have produced an enormous number of molecular structures to help solve scientific questions and support applications. Structure information makes significant contributions to the virus-related research as well. However, it is mandatory to be protected the operators under a compatible biosafety infrastructure when a pathological agent is set up in a beamline. Here a level-2 biosafety protection for a macromolecular crystallography beamline at Shanghai Synchrotron Radiation Facility (SSRF) is introduced. To fulfill the biosafety in a radioactive environment, a dedicated design is implemented. Since the beamline will be opened to the external users from nationwide research units, the management process and experimental method are also drawn up.
BibTeX
@inproceedings{kong2021implementation,
  author = {Huating Kong and Minjun Li and Qin Xu and Huan Zhou and Feng Yu and Qisheng Wang},
  title = {{Implementation of level-2 biosafety for a macromolecular crystallography beamline at SSRF.}},
  booktitle = {PubMed},
  year = {2021},
}
Figure